logo

News

    • 20TH DECEMBER 2023

    December 2023 Price Concessions 2nd Update

    Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2023) announced the following list of price concessions for December 2023. Community Pharmacy England has received a large number of reports of products not available at their Drug

    Read more
    • 20TH DECEMBER 2023

    Chief Executive’s Blog: December 2023

    By Chief Executive Janet Morrison The changing of a year is often a time to reflect on the past 12 months and consider hopes and ambitions for the months to come. So I would like to take a moment to share my pride in what the community pharmacy sector has achieved in 2023: delivering a

    Read more
    • 19TH DECEMBER 2023

    Medicine Supply Notification: Oxybutynin 5mg modified-release tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/116 Tier 2 – medium impact Date of issue 18th December 2023 Oxybutynin 5mg modified-release tablets are out of stock until early April 2024. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support increased

    Read more
    • 19TH DECEMBER 2023

    Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit . MSN/2023/051 Tier 2 – medium impact Date of issue 18th December 2023 There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens) There

    Read more
    • 18TH DECEMBER 2023

    MHRA Drug Safety Update: December 2023

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on: Aripiprazole (Abilify and generic brands): risk of pathological gambling Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions Letters and medicine recalls sent

    Read more
© 2025 Middlesex Pharmaceutical Group